Skip to main content
In stock | Targeted Therapy (Antibody / ADC)

Trastuzumab Emtansine (T-DM1)

Oncology Type Solid Tumour (Breast/Gastric)
Drug Class / Mechanism Anti-HER2 Agent
No Image
Description

Trastuzumab Emtansine (T-DM1) is classified as an Anti-HER2 Agent, sourced for use within our Targeted Therapy (Antibody / ADC) portfolio. Reach out to our team for full regulatory documentation, pricing, and current availability.

Therapeutic Category Targeted Therapy (Antibody / ADC)
Oncology Type Solid Tumour (Breast/Gastric)

Send Inquiry

Submit your details to get a formal quote for this product.

Step 1 of 3